Skip to Main Content

+

  • • Pulmonary metastases occur via hematogenous spread from primary site; lymphatic and transbronchial spread are rare

    • Secondary metastatic spread to pulmonary and mediastinal lymph nodes may occur

    • Known extrathoracic primary cancers:

    • -Multiple pulmonary lesions: Metastatic disease

      -Solitary lesions: Benign disease, 20%; new primary lung cancer, 20%; metastatic disease, 60%

    • Solitary squamous cell nodules should be addressed as a new primary lung cancer

++

Epidemiology

+

  • • 30% of patients with malignancies develop pulmonary metastases

    • 12% of isolated lung disease is totally resectable

    • 10% of patients (1.2% of all patients) have solitary lung metastases

++

Symptoms and Signs

+

  • • Most asymptomatic

    • Cough, hemoptysis, fever, dyspnea, and pain

++

Imaging Findings

+

  • • Chest film or CT scan identifies nodule(s)

+

  • • Pathologic diagnosis is essential

+

  • • Chest x-ray

    • Chest CT to assess lungs for other nodules

    • CT scans detects 3 mm nodules, with false-positive rate of 55%

    • Pathologic diagnosis is essential: obtained at the time of resection, via fine-needle aspiration, or bronchoscopy

    • Thorough search for other sites of metastasis including bone scan, head CT, or MRI

+

  • • If complete resection not possible, resection should not be offered

++

Surgery

+

  • • Wedge resection treatment of choice unless lesion is solitary squamous cell carcinoma or adenocarcinoma—treated as primary lung cancers with lobectomy and mediastinal lymph node dissection

    • Lobectomy or even pneumonectomy occasionally required if proximal pulmonary artery or bronchus involved

    • Primary tumor controlled or imminently controllable

    • No other sites of disease exist

    • No other therapy can offer comparable results

    • Low operative risk

++

Prognosis

+

  • • Best prognosis

    • -Testicular: 51% 5-year survival

      -Head-neck cancers: 47% 5-year

    • Osteogenic, sarcomas, renal cell, colon: 20-35%

    • Melanoma: 10-15% survival

    • Rectal cancer with isolated pulmonary metastasis: 55% 5-year

    • Poor prognosis:

    • -Multiple or bilateral lesions

      -> 4 lesions on CT

      -Tumor doubling time < 40 days

      -Short disease-free interval

      -Advanced age

++

References

Skubitz KM, D’Adamo DR: Sarcoma. Mayo Clin Proc 2007;82:1409.  [PubMed: 17976362]

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessSurgery Full Site: One-Year Subscription

Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessSurgery

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.